From
StayCurrentMD
Unselected CD117 Expression in Amniotic and Placental Mesenchymal Stem Cells
jpedsurg.org shows its articles on its own site.
Read the article on jpedsurg.org ↗Article · Aug 2021 · 1 min read
In brief
In brief
This article examines CD117 expression patterns in mesenchymal stem cells derived from amniotic fluid and placental tissue. These fetal MSC sources offer advantages for regenerative medicine applications due to their accessibility through minimally invasive prenatal procedures and their inherent plasticity and multilineage differentiation potential.
Written by the GCMD Library team from the article.
Mesenchymal stem cells (MSCs) have been extensively studied for over half a century. Their plasticity, self-renewal, and multilineage potential have generated unremitting interest in their use in regenerative therapy strategies. Fetal MSCs isolated from the amniotic fluid and placenta have been favored for perinatal applications largely because amniocentesis and chorionic villus sampling are minimally invasive and acceptably safe procedures.
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Video
Intestinal Atresia Types Explained: Grossfeld Classification for Pediatric Surgery
1 min · Published Sep 2026
Video
Derivation and validation of the Pediatric Community-Acquired Pneumonia Severity (PedCAPS) score: A prospective cohort study
50 s · Published Sep 2026
Video
FETO for Late-Diagnosed Severe Congenital Diaphragmatic Hernia (CDH) at Cincinnati Children's with Dr. Beth Rymeski
4 min · Published Sep 2026
Video
Severe Congenital Diaphragmatic Hernia (CDH) Case: FETO Management & Unexpected Findings with Dr. Beth Rymeski
3 min · Published Sep 2026
Video
Fetoscopic Endoluminal Tracheal Occlusion (FETO) Procedure: Step-by-Step Guide with Dr. Beth Rymeski
4 min · Published Sep 2026
Video
Choledochal Cyst Types Explained: Pediatric Surgery Fundamentals
1 min · Published Sep 2026